Richard A. Heyman's Net Worth

$4.97 Million

Estimate Recalculated Apr 16, 2024 04:06PM EST

Who is Richard A. Heyman?

Richard A. Heyman has an estimated net worth of $4.97 Million. This is based on reported shares across multiple companies, which include Enliven Therapeutics, Inc., Receptos, Inc., PMV Pharmaceuticals, Inc., Gritstone bio, Inc., BCTG Acquisition Corp., ORGANOVO HOLDINGS, INC., Metacrine, Inc., Oric Pharmaceuticals, Inc., YUMANITY THERAPEUTICS, INC., and RayzeBio, Inc..

SEC CIK

Richard A. Heyman's CIK is 0001584759

Past Insider Trading and Trends

2021 was Richard A. Heyman's most active year for acquiring shares with 10 total transactions. Richard A. Heyman's most active month to acquire stocks was the month of May. 2021 was Richard A. Heyman's most active year for disposing of shares, totalling 27 transactions. Richard A. Heyman's most active month to dispose stocks was the month of May. 2021 saw Richard A. Heyman paying a total of $959,253.75 for 94,898 shares, this is the most they've acquired in one year. In 2015 Richard A. Heyman cashed out on 26,200 shares for a total of $3,619,376.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Enliven Therapeutics, Inc. (ELVN) Snapshot price: $15.51

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-4.03%
-6.96K
$23.34
-$167,887.52
165.86K
Scheduled
Apr 11 - Apr 15
Form 4
-0.88%
-1.27K
$14.50
-$18,418.68
143.47K
Scheduled
Mar 19
Form 4
-0.87%
-1.27K
$17.42
-$22,117.43
144.74K
Scheduled
Feb 15
Form 4/A
—
0
—
—
0
Feb 13
Form 4
—
0
—
—
0
Feb 13
Form 4
-0.86%
-1.27K
$16.41
-$20,839.56
146.01K
Scheduled
Jan 30
Form 4
-0.12%
-216.00
$13.00
-$2,808.00
176.5K
Scheduled
Dec 21 - Dec 22
Form 4
-2.36%
-4.28K
$13.02
-$55,727.05
176.71K
Scheduled
Dec 19 - Dec 20
Form 4
—
0
—
—
0
Feb 23
Form 4
∞
218.4K
—
—
218.4K
Feb 23
Form 3
—
0
—
—
0
No matching records found

Receptos, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-7.40K
—
—
0
Aug 27
Form 4
∞
7.4K
—
—
7.4K
May 28
Form 4
—
0
—
—
0
Jul 28
Form 3
—
0
—
—
0
No matching records found

PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.725

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
May 12
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
$139.26
$832,318.28
0
Scheduled
Jun 1
Form 4
—
0
—
—
0
Nov 11
Form 3
—
0
—
—
0
No matching records found

Gritstone bio, Inc. (GRTS) Snapshot price: $2.14

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Jun 19
Form 3
—
0
—
—
0
No matching records found

BCTG Acquisition Corp. (TNGX) Snapshot price: $12.73

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found